Pharmacopsychiatry · 1983 · 79 citations · 0 references
MedicinePharmacotherapyPsychiatryNeuropharmacologyNeuropsychiatryPsychopharmacologyDopaminergic PharmacologyDrug DependenceParkinson DiseaseParkinsonian DisordersPsychiatric Effects Of MedicationsSexual DysfunctionDopamine-related Movement DisordersDopaminergic Drug-induced PsychosisDopaminergic Side EffectsHallucinations In Parkinson's DiseaseParkinson's Disease PharmacotherapyParkinson’s Disease PharmacotherapyParkinson’s Disease TreatmentPatient Dose Reduction
Hypersexuality induced by dopaminergic drug treatment in parkinsonian patients is a rarely reported side-effect. A case history is presented where it occurred together with hyperkinesias while the patient was treated with L-dopa and bromocriptine. An addictive misuse of these drugs complicate the guidance of this patient. Approximately three years after the beginning of hypersexuality he developed several paranoid-hallucinatory psychoses which subsided each time upon dose reduction.